ArticleGene therapy2020

Neonatal nonviral gene editing with the CRISPR/Cas9 system improves some cardiovascular, respiratory, and bone disease features of the mucopolysaccharidosis I phenotype in mice.

Roselena Silvestri Schuh et al.PubMed ↗Publisher ↗

No numbers read from the abstract.